These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14504973)

  • 1. HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Zacchi T; Nasuelli D; Ukmar M; Furlan C; Pozzi-Mucelli R; Tommasi MA; Locatelli L; Ulivi S; Bratina A; Bosco A; Grop A; Cazzato G; Zorzon M
    J Neurol; 2003 Sep; 250(9):1099-106. PubMed ID: 14504973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
    Zivadinov R; Weinstock-Guttman B; Zorzon M; Uxa L; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M
    J Neuroimmunol; 2009 Apr; 209(1-2):123-30. PubMed ID: 19232441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
    Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
    Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
    Fernández O; Fernández V; Alonso A; Caballero A; Luque G; Bravo M; León A; Mayorga C; Leyva L; de Ramón E
    J Neurol; 2004 Apr; 251(4):440-4. PubMed ID: 15083289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
    Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR
    Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients.
    Zivadinov R; Nasuelli D; Tommasi MA; Serafin M; Bratina A; Ukmar M; Pirko I; Johnson AJ; Furlan C; Pozzi-Mucelli RS; Monti-Bragadin L; Grop A; Zambon M; Antonello RM; Cazzato G; Zorzon M
    Neurol Res; 2006 Apr; 28(3):262-9. PubMed ID: 16687051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relation between the HLA-DRB1*1501 allele and the severity of multiple sclerosis in a sample of the Spanish population from the Balearic Islands: the influence exerted by sex].
    Zabay-Becerril JM; Burcet-Dardé J; Mulet-Ferrer J; Soler-Farré J; Viader-Farré C
    Rev Neurol; 2004 Jan 16-31; 38(2):118-22. PubMed ID: 14752708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].
    Wu XM; Zhang KN; Wang CD; Xiong YQ; Liu Z; Qu XH; Xie XF
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2741-4. PubMed ID: 18167262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DRB1*1501 and spinal cord magnetic resonance imaging lesions in multiple sclerosis.
    Sombekke MH; Lukas C; Crusius JB; Tejedor D; Killestein J; Arteta D; Martínez A; Uitdehaag BM; Knol DL; Peña AS; Geurts JJ; De Jager PL; Barkhof F; Vrenken H; Polman CH
    Arch Neurol; 2009 Dec; 66(12):1531-6. PubMed ID: 20008659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin.
    Martorana D; Vaglio A; Greco P; Zanetti A; Moroni G; Salvarani C; Savi M; Buzio C; Neri TM
    Arthritis Rheum; 2006 Feb; 55(1):126-30. PubMed ID: 16463424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
    Zivadinov R; Bagnato F; Nasuelli D; Bastianello S; Bratina A; Locatelli L; Watts K; Finamore L; Grop A; Dwyer M; Catalan M; Clemenzi A; Millefiorini E; Bakshi R; Zorzon M
    J Neurol Sci; 2004 Aug; 223(2):185-93. PubMed ID: 15337621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression.
    Baronica KB; Mlinac K; Ozretić D; Vladić A; Bognar SK
    Coll Antropol; 2011 Jan; 35 Suppl 1():11-6. PubMed ID: 21648305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
    Mesaros S; Rocca MA; Absinta M; Ghezzi A; Milani N; Moiola L; Veggiotti P; Comi G; Filippi M
    Neurology; 2008 Mar; 70(13 Pt 2):1107-12. PubMed ID: 18272867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
    Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
    J Neurol Sci; 2010 Nov; 298(1-2):96-100. PubMed ID: 20810130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.